title: Extended release tacrolimus and antiretroviral therapy in a renal transplant recipient: so extended!
authors.forename: Johann
authors.initials: J
authors.lastname: Morelle
authors.forename: Eric
authors.initials: E
authors.lastname: Goffin
authors.forename: Pierre
authors.initials: P
authors.lastname: Wallemacq
authors.forename: Martine
authors.initials: M
authors.lastname: De Meyer
authors.forename: Jean-Cyr
authors.initials: JC
authors.lastname: Yombi
authors.forename: Michel
authors.initials: M
authors.lastname: Mourad
authors.forename: Nada
authors.initials: N
authors.lastname: Kanaan
mesh_terms: D044966:Anti-Retroviral Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016030:Kidney Transplantation / Q000379:methods*; D061466:Lopinavir; D008297:Male; D008875:Middle Aged; D011744:Pyrimidinones / Q000009:adverse effects*; D016559:Tacrolimus / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D044966:Anti-Retroviral Agents; D003692:Delayed-Action Preparations; D007166:Immunosuppressive Agents; D011744:Pyrimidinones; D061466:Lopinavir; D016559:Tacrolimus